Antares pharma, inc. (ATRS)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Current Assets:
Cash and cash equivalents

33,814

23,201

41,874

40,171

23,238

27,892

28,160

28,782

23,111

26,562

27,433

33,418

23,677

27,715

-

-

-

32,898

-

43,124

23,543

-

41,017

39,057

39,067

42,960

35,914

38,126

52,097

12,159

17,973

18,167

19,357

17,118

33,327

9,847

Cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,781

27,559

30,102

-

35,880

-

-

34,028

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

16,503

22,520

-

-

-

0

0

0

4,997

4,993

9,976

9,960

-

0

3,001

9,004

12,009

15,012

12,008

6,001

3,001

6,002

15,004

21,002

24,014

27,053

33,099

30,154

21,112

18,051

12,024

12,026

12,011

-

-

0

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,996

-

-

Accounts receivable

31,412

35,074

33,931

24,629

29,772

18,976

15,483

14,072

12,494

11,878

10,146

9,067

7,884

9,073

8,561

10,295

7,976

7,952

6,558

6,449

4,208

3,510

3,065

3,648

1,034

3,405

4,330

1,729

2,228

2,051

2,630

1,409

2,535

1,986

1,301

1,245

Inventories

17,309

16,000

16,503

15,235

13,378

11,350

11,275

10,680

9,929

9,275

7,942

7,845

6,852

5,327

6,723

7,458

5,270

5,724

5,657

5,465

5,896

5,859

8,334

7,106

6,461

1,804

1,028

705

1,002

875

867

1,312

891

351

422

272

Contract assets

9,929

8,235

6,199

6,285

9,445

10,442

-

-

-

505

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred costs

-

-

-

-

-

-

275

411

432

-

1,213

893

1,712

1,773

1,961

2,141

2,049

1,199

519

943

1,708

1,913

1,062

545

375

317

757

895

755

773

1,892

1,641

1,111

1,197

1,077

915

Prepaid expenses and other current assets

3,365

3,416

1,429

2,781

3,657

2,648

1,806

1,915

2,074

2,323

1,680

1,690

1,520

1,376

376

2,716

3,178

3,274

2,023

2,849

3,006

2,322

1,030

996

1,706

1,001

868

688

463

983

460

253

357

255

217

193

Total current assets

112,332

108,446

99,936

89,101

79,490

71,308

56,999

55,860

53,037

55,536

58,393

62,875

41,646

45,264

49,405

59,175

60,585

66,061

62,648

64,834

41,364

53,637

69,515

72,355

72,659

76,542

75,998

72,300

77,659

34,895

35,847

34,809

36,265

29,905

36,346

12,475

Long-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,047

-

-

Equipment, molds, furniture and fixtures, net

16,223

15,961

15,409

14,994

15,100

14,895

15,325

15,569

15,892

16,158

17,296

17,550

17,607

17,867

17,993

17,356

17,142

14,793

13,831

13,558

13,105

10,828

8,613

7,632

6,952

6,013

5,291

4,299

3,583

3,262

1,482

770

591

494

463

327

Operating lease right-of-use assets

5,193

5,463

5,462

2,947

1,910

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patent rights, net

-

-

-

-

-

-

998

1,133

1,267

-

1,630

1,766

1,924

2,045

2,149

2,224

2,331

2,434

2,551

2,700

2,778

2,885

2,630

2,124

1,345

1,217

1,134

1,112

1,123

1,173

1,043

976

952

921

943

803

Goodwill

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

1,095

Intangibles, net

448

478

508

556

688

831

-

-

-

1,401

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

408

Long-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,006

9,016

-

-

-

3,005

6,008

0

6,009

12,013

12,015

3,019

3,019

3,006

3,026

-

-

0

Other assets

1,513

1,308

519

519

502

148

148

148

148

148

53

53

53

54

153

153

153

177

326

326

326

325

871

871

871

61

61

61

49

58

58

68

31

31

31

31

Total Assets

136,804

132,751

122,929

109,212

98,785

88,277

74,565

73,805

71,439

74,338

78,470

83,342

62,328

66,325

70,797

80,006

81,308

84,562

83,459

91,532

58,669

68,772

82,725

87,084

88,931

84,930

89,590

90,882

95,526

43,504

42,547

40,726

41,962

38,495

38,880

15,141

Liabilities and Stockholders’ Equity
Current Liabilities:
Accounts payable

18,184

12,905

16,530

11,699

15,622

11,135

7,497

6,577

6,652

5,957

8,245

8,478

8,687

7,885

8,096

10,825

6,960

5,187

2,392

4,762

8,852

10,071

6,461

5,679

6,378

4,689

5,180

3,171

2,864

2,819

2,617

2,927

2,139

1,829

2,285

1,773

Accrued expenses and other liabilities

15,743

16,523

14,966

12,571

11,844

11,997

9,124

9,063

6,868

6,982

6,394

6,172

7,108

5,873

6,656

6,958

8,530

6,488

5,745

5,657

4,759

5,635

8,419

5,428

5,453

4,863

2,782

1,758

2,916

2,631

2,121

1,736

2,225

1,652

1,140

1,818

Long-term debt, current portion

-

-

-

-

4,933

3,043

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, current portion

1,286

1,249

975

961

866

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred gain

-

-

-

-

-

-

7,500

7,500

2,750

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

2,048

1,738

1,412

547

1,537

1,018

811

-

-

2,794

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

827

1,797

-

2,842

3,483

3,928

6,149

5,801

6,494

5,254

5,143

1,980

3,029

7,435

8,520

7,306

6,182

4,531

633

1,288

1,466

2,157

1,929

2,968

3,176

5,644

3,278

3,250

3,080

Total current liabilities

37,261

32,415

33,883

25,778

34,802

27,193

24,932

23,967

18,067

15,733

17,482

18,133

19,724

19,907

20,554

24,278

20,744

16,819

10,119

13,450

21,047

24,227

22,187

17,290

16,363

10,187

9,251

6,396

7,938

7,380

7,707

7,840

10,008

6,761

6,676

6,672

Long-term debt

40,521

40,395

40,269

40,143

20,260

22,083

25,059

24,992

24,925

24,858

24,791

24,724

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, long-term

5,224

5,441

4,362

1,739

1,055

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue – long term

-

-

-

-

-

-

200

-

-

200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue long term

-

-

-

-

-

-

-

200

200

-

200

200

1,200

1,200

1,200

1,200

680

700

719

738

2,472

3,349

5,102

5,978

1,855

874

893

913

1,037

452

471

790

810

839

869

1,842

Total liabilities

83,006

78,251

78,514

67,660

56,117

49,276

50,191

49,159

43,192

40,791

42,473

43,057

20,924

21,107

21,754

25,478

21,425

17,519

10,838

14,188

23,519

27,576

27,289

23,269

18,218

11,062

10,145

7,309

8,976

7,833

8,178

8,631

10,819

7,600

7,545

8,514

Stockholders’ Equity:
Preferred Stock: $0.01 par; 3,000 shares authorized, none outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

0

0

0

0

0

Common Stock: $0.01 par; 300,000 shares authorized; 165,560 and 165,221 issued and outstanding at March 31, 2020 and December 31, 2019, respectively

1,656

1,652

1,632

1,630

1,625

1,597

1,575

1,574

1,568

1,567

1,564

1,563

1,554

1,552

1,550

1,550

1,549

1,548

1,548

1,548

1,317

1,317

1,303

1,299

1,287

1,272

1,270

1,261

1,259

1,097

1,066

1,039

1,035

1,035

1,030

841

Additional paid-in capital

334,025

332,377

326,895

325,075

323,972

314,907

306,435

304,770

303,847

302,965

301,703

300,537

298,837

297,826

297,136

296,503

295,792

295,292

294,252

293,215

249,761

249,032

245,974

245,256

243,375

240,919

240,158

239,193

238,745

183,040

178,246

173,126

172,065

171,634

170,745

143,318

Accumulated deficit

-281,183

-278,827

-283,406

-284,449

-282,223

-276,800

-282,934

-280,998

-276,478

-270,285

-266,570

-261,118

-258,278

-253,445

-248,945

-242,824

-236,762

-229,106

-222,480

-216,741

-215,235

-208,447

-191,188

-182,090

-173,295

-167,660

-161,300

-156,197

-152,789

-147,777

-144,243

-141,436

-141,361

-141,207

-139,908

-136,973

Accumulated other comprehensive loss

-700

-702

-706

-704

-706

-703

-702

-700

-690

-700

-700

-697

-709

-715

-699

-702

-696

-691

-699

-677

-693

-705

-653

-651

-653

-662

-683

-684

-665

-689

-700

-635

-595

-566

-533

-559

Total Stockholders' Equity

53,798

54,500

44,415

41,552

42,668

39,001

24,374

24,646

28,247

33,547

35,996

40,284

41,403

45,218

49,043

54,527

59,883

67,042

72,620

77,343

35,150

41,196

55,436

63,814

70,713

73,868

79,444

83,572

86,550

35,671

34,368

32,094

31,143

30,894

31,334

6,626

Total Liabilities and Stockholders’ Equity

136,804

132,751

122,929

109,212

98,785

88,277

74,565

73,805

71,439

74,338

78,470

83,342

62,328

66,325

70,797

80,006

81,308

84,562

83,459

91,532

58,669

68,772

82,725

87,084

88,931

84,930

89,590

90,882

95,526

43,504

42,547

40,726

41,962

38,495

38,880

15,141